China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China
· Delayed Price · Currency is CNY 17.72
+0.15 (0.85%)
Apr 29, 2026, 3:04 PM CST
SHE:300294 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 8,860 | 11,396 | 15,269 | 16,983 | 18,435 | 19,338 | Upgrade
|
| Market Cap Growth | -34.64% | -25.36% | -10.10% | -7.88% | -4.67% | 35.36% | Upgrade
|
| Enterprise Value | 6,060 | 8,289 | 10,035 | 11,919 | 13,978 | 17,731 | Upgrade
|
| Last Close Price | 17.57 | 22.60 | 29.91 | 32.80 | 35.41 | 36.96 | Upgrade
|
| PE Ratio | 2579.16 | 101.12 | 38.46 | 71.52 | 42.66 | 56.13 | Upgrade
|
| Forward PE | 24.07 | 19.56 | 26.00 | 29.00 | 30.95 | 32.40 | Upgrade
|
| PS Ratio | 4.80 | 5.53 | 8.80 | 6.40 | 6.68 | 7.30 | Upgrade
|
| PB Ratio | 1.19 | 1.53 | 2.04 | 2.32 | 2.53 | 2.79 | Upgrade
|
| P/TBV Ratio | 1.40 | 1.80 | 2.55 | 2.43 | 2.97 | 3.23 | Upgrade
|
| P/FCF Ratio | - | - | 149.71 | 30.64 | 40.25 | 15.14 | Upgrade
|
| P/OCF Ratio | - | 186.32 | 50.93 | 26.47 | 30.91 | 14.37 | Upgrade
|
| EV/Sales Ratio | 3.29 | 4.03 | 5.78 | 4.49 | 5.07 | 6.69 | Upgrade
|
| EV/EBITDA Ratio | 19.38 | 19.93 | 19.23 | 19.09 | 23.28 | 34.72 | Upgrade
|
| EV/EBIT Ratio | 39.35 | 30.37 | 23.77 | 22.52 | 27.56 | 42.78 | Upgrade
|
| EV/FCF Ratio | -9.66 | - | 98.40 | 21.51 | 30.52 | 13.88 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.24 | 0.16 | 0.02 | 0.04 | 0.06 | 0.07 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.12 | 0.04 | 0.08 | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.37 | -0.42 | -0.47 | -0.72 | -0.64 | -0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | -9.11 | -7.61 | -6.68 | -8.49 | -7.81 | -8.32 | Upgrade
|
| Net Debt / FCF Ratio | 4.47 | 6.68 | -34.18 | -9.56 | -10.24 | -3.33 | Upgrade
|
| Asset Turnover | 0.22 | 0.24 | 0.21 | 0.33 | 0.35 | 0.42 | Upgrade
|
| Inventory Turnover | 0.96 | 1.05 | 0.79 | 2.06 | 1.87 | 1.74 | Upgrade
|
| Quick Ratio | 4.87 | 4.06 | 5.40 | 12.85 | 7.65 | 7.83 | Upgrade
|
| Current Ratio | 6.32 | 5.06 | 6.74 | 14.08 | 8.61 | 8.95 | Upgrade
|
| Return on Equity (ROE) | 0.04% | 1.51% | 5.36% | 3.40% | 6.27% | 6.45% | Upgrade
|
| Return on Assets (ROA) | 1.14% | 2.00% | 3.25% | 4.17% | 4.05% | 4.05% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.45% | 6.60% | 11.64% | 16.09% | 16.13% | 10.41% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.00% | 3.60% | 5.50% | 7.20% | 6.90% | 5.90% | Upgrade
|
| Earnings Yield | 0.04% | 0.99% | 2.60% | 1.40% | 2.34% | 1.78% | Upgrade
|
| FCF Yield | -7.08% | -4.16% | 0.67% | 3.26% | 2.48% | 6.60% | Upgrade
|
| Dividend Yield | 1.24% | 0.99% | 1.07% | 0.92% | 0.56% | 0.41% | Upgrade
|
| Payout Ratio | 4561.28% | 138.77% | 58.54% | 42.47% | 19.25% | 13.36% | Upgrade
|
| Buyback Yield / Dilution | -2.65% | -1.94% | 0.54% | -0.53% | -15.24% | -2.30% | Upgrade
|
| Total Shareholder Return | -1.41% | -0.95% | 1.61% | 0.38% | -14.67% | -1.89% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.